Exosome Research Market to be Led by Kits and Reagents Through 2028

Advancements in exosome isolation and analysis are expected to drive the global exosome research market during the forecast period.

According to the TechSci Research report, “Exosome Research Market - Global Industry Size, Share, Trends, Opportunities, and Forecast, 2018-2028,” the exosome research market worldwide is anticipated to grow at an impressive rate in the forecast period. This can be ascribed to the growing technological advancements in exosome isolation and analytical procedures, growth in government and non-government initiatives for exosome research, and the increasing prevalence of cancer across the world.

Additionally, the growing need for the identification of cancer biomarkers, detection of infectious agents, and discovery of treatment options for neurodegenerative & cardiovascular diseases (CVDs) are the major factors driving the growth of the market during the forecast period. Also, the rising demand for fast, accurate, and minimally invasive diagnostic procedures, thus, represents a promising opportunity for the growth of exosome applications, which will further boost the global exosome research market during the forecast period.

Besides, increased research programs concentrating on ascertaining the importance of exosomes in hepatocellular carcinoma (HCC) are driving the demand for the exosome research market during the forecast period. However, there is currently a lack of standardized protocols for exosome isolation, analysis, and characterization, which can make it difficult for researchers to compare and replicate findings across studies, which can slow down the growth of the market during the forecast period. Also, the regulatory environment for exosome-based products and services is complex and evolving which may restrict the growth of the global exosome research market. Similarly, the current methods for exosome isolation and analysis can be time-consuming and costly which may hamper the growth of the market during the forecast period.

Browse over XX market data figures spread through xx pages and an in-depth TOC on the “Global Exosome Research Market.”

The exosome research market can be segmented by product, indication, application, and region.

Based on the product, the global market can be segmented into kits and reagents, instruments, and other products. The kits and reagents segment dominated the market in 2022 and is expected to continue maintaining its dominance throughout the forecast period. This can be attributed to the increase in the need for molecular diagnosis and the surge in R&D activities for diagnosis due to advancements in R&D activities in the healthcare sector and an increase in the number of key manufacturers.

Based on application, the market can be grouped into biomarkers, vaccine development, tissue regeneration, and other applications. The biomarkers segment is expected to dominate during the forecast period on account of the growing demand for the treatment of different cancers, such as melanoma patients, and the increasing incidence of neurodegenerative disease. Also, growing research and development activities for novel drugs for the treatment of chronic diseases are expected to create lucrative growth opportunities during the forecast period.

Major companies operating in the global exosome research market are:

• Thermo Fisher Scientific
• System Biosciences
• Bio-Techne
• Lonza
• QIAGEN
• ExoDx
• Hitachi Chemical
• Aethlon Medical
• NanoSomiX
• Malvern Panalytical
• Sistemic Scotland Limited
• NX PharmaGen

July 2022: Cells for Cells, a clinical-stage biotech pioneering allogeneic stem cell and stem-cell-derived therapeutics for high-impact chronic diseases, announced a 6-month follow-up of the groundbreaking clinical data from the first-ever patient dosed with an exosome-produced therapy for osteoarthritis.

April 2022: Global Stem Cells Group (GSCG) announced the launch of its new product with new lyophilized exosome technology. Global Stem Cells Group's new product line includes innovative anti-aging products that can regenerate cells and tissues in the body.

November 2021: Lonza, a global manufacturing partner to the pharma, biotech, and nutrition industries, announced the acquisition of an exosome manufacturing facility in Lexington, Massachusetts (US) from Codiak BioSciences, a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics.

Download Free Sample Report

Customers can also request 10% free customization on this report.

“North America is expected to dominate the global exosome research market during the forecast period on account of the improved healthcare facilities, efficacious government initiatives, a large foundation of multi-national corporations, and increased public consciousness concerning diagnostics and medicare. Similarly, A huge proportion of government-funded scientific analyses have been performed on the vocation of drugs containing exosomes in various types of cancers, including melanoma, breast cancer, lung cancer, and pancreatic cancer, among many that are expected to create lucrative growth in the market during the forecast period. Also, the increasing wide uptake of emerging micro-nanotechnologies for extracellular vesicles in immuno-oncology ranging from target-specific isolations to immunomodulation is expected to drive the growth of the market during the forecast period.

Furthermore, a surge in government-funded research studies, conducted regarding the role of drugs using exosomes in several types of cancer, such as melanoma, breast cancer, lung cancer, and pancreatic cancer, will further be expected to create lucrative opportunities for market growth,” said Mr. Karan Chechi, Research Director at TechSci Research, a research-based global management consulting firm.

Exosome Research Market - Global Industry Size, Share, Trends, Opportunities, and Forecast, 2018-2028, Segmented by Product (Kits and Reagents, Instruments, and Other Products), By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, and Others), By Application (Biomarkers, Vaccine Development, Tissue Regeneration, and Other Applications), By Region and Competition has evaluated the future growth potential of global exosome research market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision-makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the global exosome research market.

Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com